Evaluation of the EIE-IgM-Leptospirose assay for the serodiagnosis of leptospirosis
- PMID: 17618860
- PMCID: PMC1994159
- DOI: 10.1016/j.actatropica.2007.05.002
Evaluation of the EIE-IgM-Leptospirose assay for the serodiagnosis of leptospirosis
Abstract
Access to low-cost, effective diagnosis for leptospirosis is urgently needed in developing countries. The EIE-IgM-Leptospirose, a kit produced for public health laboratories in Brazil, was shown to have a sensitivity of 76% (77 of 102 patients) and 100% (102 of 102 patients) during acute and convalescent-phase leptospirosis, respectively, and a specificity of 93-100% (total healthy and patient control subjects evaluated, 486). These findings indicate that the assay will be useful for diagnosis of this emerging infectious disease in Brazil and other developing countries.
Figures
References
-
- Abdulkader RC, Daher EF, Camargo ED, Spinosa C, da Silva MV. Leptospirosis severity may be associated with the intensity of humoral immune response. Rev Inst Med Trop Sao Paulo. 2002;44:79–83. - PubMed
-
- Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3:757–771. - PubMed
-
- Cumberland P, Everard COR, Wheeler JG, Levett PN. Persistence of anti-leptospiral IgM, IgG and agglutinating antibodies in patients presenting with acute febrile illness in Barbados 1979–1989. Eur J Epidemiol. 2001;17:601–608. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
